The Advisory Board Company (NASDAQ:ABCO) released its earnings results on Tuesday. The business services provider reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by $0.08, Morningstar.com reports. The business had revenue of $200.30 million during the quarter, compared to the consensus estimate of $196.16 million. The Advisory Board had a net margin of 12.78% and a return on equity of 14.48%. The business’s revenue was up 1.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.46 earnings per share. The Advisory Board updated its FY17 guidance to $1.80 – $2.10 EPS.

The Advisory Board (ABCO) opened at 52.05 on Wednesday. The Advisory Board has a one year low of $24.85 and a one year high of $59.50. The company has a market capitalization of $2.11 billion, a price-to-earnings ratio of 21.09 and a beta of 1.33. The firm’s 50-day moving average price is $54.47 and its 200 day moving average price is $49.35.

Several large investors have recently modified their holdings of ABCO. Victory Capital Management Inc. acquired a new stake in shares of The Advisory Board during the first quarter worth about $109,000. Rockefeller Financial Services Inc. acquired a new stake in shares of The Advisory Board during the second quarter worth about $137,000. Howard Hughes Medical Institute acquired a new stake in shares of The Advisory Board during the first quarter worth about $158,000. Asset Management One Co. Ltd. acquired a new stake in shares of The Advisory Board during the first quarter worth about $159,000. Finally, Ameritas Investment Partners Inc. acquired a new stake in shares of The Advisory Board during the first quarter worth about $166,000.

Several equities analysts have recently issued reports on the company. BidaskClub lowered The Advisory Board from a “hold” rating to a “sell” rating in a report on Saturday. Zacks Investment Research lowered The Advisory Board from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 25th. Robert W. Baird reaffirmed an “outperform” rating and issued a $65.00 target price (up from $57.00) on shares of The Advisory Board in a report on Sunday, July 9th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $53.00 target price (up from $48.00) on shares of The Advisory Board in a report on Thursday, July 6th. Finally, Credit Suisse Group upped their target price on The Advisory Board from $54.00 to $55.00 and gave the company an “outperform” rating in a report on Monday, May 15th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $50.33.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece on another publication, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/08/08/the-advisory-board-company-nasdaqabco-posts-quarterly-earnings-results-misses-estimates-by-0-07-eps.html.

The Advisory Board Company Profile

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.

Earnings History for The Advisory Board (NASDAQ:ABCO)

Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.